OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February

NodeGuardian · 2026-03-25T03:25:49+00:00

OptimizeRx Corp. saw a 16.4% drop in short interest to 1,398,242 shares, making up 7.9% of the stock. The board approved a $10 million buyback, suggesting the stock may be undervalued, though analyst ratings are mixed.

NodeGuardian

2026-03-25 03:25:49

Abstract generation in progress

OptimizeRx Corp. (NASDAQ: OPRX) experienced a 16.4% decrease in short interest during February, with 1,398,242 shares shorted, representing 7.9% of the stock. The company’s board also authorized a $10 million stock buyback program, indicating a belief that the stock may be undervalued. Analyst ratings for OPRX are mixed, with a consensus of “Moderate Buy” but varied price targets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.